Erech Finance Cahalacha Ltd (EFNC.TA)
Erech Finance Cahalacha Ltd operates in the Medical - Devices industry of the Healthcare sector, headquartered in Jerusalem, IL. The stock last traded at $267.50, down 5.64% on the session, giving a market capitalisation of $6.8M. Its beta of 1.35 implies it has historically moved more than the broad market.
Erech Finance Cahalacha Ltd, including its subsidiaries, provides diverse lending and credit solutions to small and medium-sized businesses, associations, and individual clients across Israel. The company's operations are structured into two main divisions: Non-Bank Credit and Biomed Drug. Additionally, Erech Finance Cahalacha Ltd is engaged in pharmaceutical research and development, concentrating on treatments for diabetes and cancer. Its corporate headquarters are located in Jerusalem, Israel.
Erech Finance Cahalacha Ltd is most often compared with the following Healthcare names: